利索-全球专利检索

  1. 登录
  2. 注册
发明公开
CN106191127A 干细胞生物活性组合物及其制备方法与应用 有权 转让

干细胞生物活性组合物及其制备方法与应用
摘要：
本发明公开了一种干细胞生物活性组合物及其制备方法与应用，所述干细胞生物活性组合物含有1.69-22.24pg/mL EGF、2443.17-4459.43pg/mL bFGF、1.44-134.36pg/mL beta-NGF、1.55-355.14pg/mL VEGF、11.87-159.70pg/mL PDGF-DD、135.79-688.13pg/mL KGF、1176.99-3825.79pg/mL TGF-β1，所述干细胞生物活性组合物具有高纯度、高产量、高生物活性。
摘要（英）：

The invention discloses a stem cell bioactive composition and a preparation method and application thereof. The stem cell bioactive composition comprises 1.69 to 22.24 pg/mL of EGF (epidermal growth factor), 2443.17 to 4459.43 pg/mL of bFGF (basic fibroblast growth factor), 1.44 to 134.36 pg/mL of beta-NGF (Beta-nerve growth factor), 1.55 to 355.14 pg/mL of VEGF (vascular endothelial growth factor), 11.87 to 159.70 pg/mL of PDGF-DD (platelet-derived growth factor), 135.79 to 688.13 pg/mL of KGF (keratinocyte growth factor), and 1176.99 to 3825.79 pg/mL of TGF-Beta1 (transforming growth factor beta-1); the stem cell bioactive composition has high purity, high yield and high bioactivity.

公开/授权文献
0/0